Insiders hold 43% of Vivani Medical, Inc. (NASDAQ:VANI), and they've been buying recently
AI Sentiment
Positive
7/10
as of 12-09-2025 4:00pm EST
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | ALAMEDA |
| Market Cap: | 81.2M | IPO Year: | 2014 |
| Target Price: | $4.00 | AVG Volume (30 days): | 160.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.91 - $1.92 | Next Earning Date: | 11-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Director, 10% Owner
Avg Cost/Share
$1.19
Shares
1,737,764
Total Value
$1,983,332.68
Owned After
22,824,029
Director, 10% Owner
Avg Cost/Share
$1.62
Shares
3,703,703
Total Value
$5,999,998.86
Owned After
22,824,029
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$1.19
Shares
1,737,764
Total Value
$1,983,332.68
Owned After
22,824,029
Director, 10% Owner
Avg Cost/Share
$1.19
Shares
2,068,453
Total Value
$2,400,000.68
Owned After
22,824,029
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Williams Gregg | VANI | Director, 10% Owner | Nov 15, 2025 | Buy | $1.19 | 1,737,764 | $1,983,332.68 | 22,824,029 | |
| Williams Gregg | VANI | Director, 10% Owner | Oct 27, 2025 | Buy | $1.62 | 3,703,703 | $5,999,998.86 | 22,824,029 | |
| Williams Gregg | VANI | Director, 10% Owner | Oct 15, 2025 | Buy | $1.19 | 1,737,764 | $1,983,332.68 | 22,824,029 | |
| Williams Gregg | VANI | Director, 10% Owner | Sep 15, 2025 | Buy | $1.19 | 2,068,453 | $2,400,000.68 | 22,824,029 |
VANI Breaking Stock News: Dive into VANI Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
7/10
See how VANI stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "VANI Vivani Medical Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.